Full index of posts »
Latest Followers
StockTalks
-
Market technicals: I'm accumulating both QID and DXD as the DOW and nasdaq look tired. We have not been able to surpass 10479.
Dec 23, 2009
-
Amln: today's pullback is a great entry hedged by writing Jan 12.50 calls. Last week's results of Byetta far exceeded epxectations.
Dec 23, 2009
-
QID: added more to my core position at 20.48. Nasdaq is topping out and is tiring.
Dec 11, 2009
Latest Comments
-
thirstycamel on Keep and eye on BMY and AZN for their diabetes drug Dapagliflozin. Jack,Take a look at LXRX's LX4211. It also inhi...
-
Alice4321us on Bargain stocks in the wake of an overvalued general market Jack - What is the minimum amount needed to inv...
-
Macro_Man on Stocks have gone up wild Patience my friend...every DOG has his day :). ...
-
Jack Haddad on BAC: Countrywide and Merrill mergers should boost the bank's profits 17.50 is correct
-
Macro_Man on Bought DOG and wrote November strike 56 calls. Why not wait mate. DOW is so close to 10,000 th...
Most Commented
- Exited QID's intraday bounce trade. (8 Comments)
- UNG is a strong buy at 15.35 hedged against the June strike 15 calls. (7 Comments)
- Increasd position on UNG and wrote more June strike 15 calls (6 Comments)
- MACD has turned bearish for all major indexes: DOW, NASDAQ, and S&P500 (5 Comments)
- Re-entered M for an intraday bounce trade. (5 Comments)
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
View Jack Haddad's Instablogs on:
Java is a perfect pullback "buy" opportunity!
Yesterday, I purchased 1 block at 6.55 and wrote 100 May strike 5 at 2.00 for an intrinsic time value of .45/contract. This isn't an anemic return in 51/2 remaining weeks to option expiration. Besides, if the shares don't get called by expiration, holding the stock at 5 or below is nearly 4.50 points below the tender IBM offer!
These are the type of anomalies that I strive to look for.
Unfair ruling on Amylin recent FDA meeting. Shares are a strong buy!
Amylin has retreated nearly 25% in one week. Shares have fallen after a link between thyroid cancer in animals and Novo Nordisk's liraglutide was brought to light during a meeting of a Food and Drug Administration advisory panel last week. I'm adamant that the risk whch the FDA took into consideration is exagerrated. Exenatide and liraglutide are not only different molecules, but cases of of thyroid cancer have not been documented in patients enrolled in the clinical trials.
I purchased 1/2 a block at 9.25 and wrote 50 may strike 10 calls at 1.10/contract. I plan on dollar cost averaging at the proper pivatol points as well as rolling options moth after month, until i feel the shares have matured.
WFC: The May strike 10 calls offer a reasonable intrinsic time value
I purchased 1/2 block (5000 shares) of WFC at 15.21 and hedged the shares by writing 50 May strike 10 calls at 5.91 for an intrinsic time value premium of .71contract. If the shares get called away by the third week of May, I pocket 3,5550.00 on a 76,050 investment in reoughly 5 1/2 weeks. If the shares are below the strrike of 10 by option expiration, it will be a good further hold nevertheless, considering the much improved conditions in the health of the financial markets.
I welcome all constructive criticism.